Praised for 'its extraordinary level of specialisation in industry regulation and global compliance', Beccar Varela advises clients across the pharmaceutical products, medical devices, cosmetics, digital health, and healthcare services sectors, providing support on transactions, IP, contentious matters, and regulatory issues. The team also works in specialised areas such as orphan products, the exception access regime for pharmaceutical products, medicinal cannabis, and clinical trials, and has recently expanded its work to include telemedicine, electronic prescriptions, and electronic pharmacies. The practice is led by Ana Andrés, who has over a decade of experience advising local and international life sciences clients on regulatory, corporate, and litigation matters. She is supported by Luciana Malito and Cruz Ignacio Uranga, both of whom focus on transactional and corporate mandates.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Their most notable qualities include their comprehensive understanding of the health sciences ecosystem, ranging from scientific foundations to commercial implications; their ability to anticipate global regulatory trends and proactively prepare their clients; and their collaborative approach that integrates different areas of expertise to offer truly comprehensive solutions.'
- 'Beccar Varela's life sciences team stands out for its exceptional level of commitment, professionalism and ability to approach complex cases with a comprehensive perspective.'
Key clients
- Haleon Argentina
- ABBVIE
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Ana Andrés
Other key lawyers
Luciana Malito; Cruz Ignacio Uranga